This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Cyranoski D. Mystery deepens over animal source of coronavirus. Nature. 2020;579: 18–19.CyranoskiDMystery deepens over animal source of coronavirus2020579181910.1038/d41586-020-00548-wSearch in Google Scholar
Balwin R, di Mauro BW. Economics in the time of COVID-Centre for Economic Policy Research 2020, Introduction 5–6, ISBN: 978-1-912179-28-2BalwinRdi MauroBWISBN: 978-1-912179-28-2Search in Google Scholar
Editorial COVID-19: learning from experience. The Lancet. 2020;395: 10229. Available from: doi: 10.1016/S0140-6736(20)30686-3Editorial COVID-19: learning from experience202039510229Available from:10.1016/S0140-6736(20)30686-3Open DOISearch in Google Scholar
Lancet Inf Dis Article: Here. Mobile Version: Here. Visualization: JHU CSSE. Automation Support: Esri Living Atlas team and JHU APL. Contact US. FAQ. Data sources: WHO, CDC, ECDC, NHC, DXY, 1point3acres, Worldometers.info, BNO, state and national government health departments, and local media reports. Read more in this blog.Contact US. FAQ. Data sources: WHO, CDC, ECDC, NHC, DXY, 1point3acres, Worldometers.info, BNO, state and national government health departments, and local media reports. Read more in this blog.Search in Google Scholar
Park JE, Jung S, Kim A. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1): 574. Available from: doi: 10.1186/s12889-018-5484-8ParkJEJungSKimAMERS transmission and risk factors: a systematic review2018181574Available from:10.1186/s12889-018-5484-8Open DOISearch in Google Scholar
Arcavi L, Benowitz NL. Cigarette smoking and infections. Archives of Internal Medicine. 2004;164(20): 2206.ArcaviLBenowitzNLCigarette smoking and infections200416420220610.1001/archinte.164.20.2206Search in Google Scholar
Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tobacco Induced Diseases. 2020;18: 20. Available from: doi: 10.18332/tid/119324VardavasCINikitaraKCOVID-19 and smoking: a systematic review of the evidence20201820Available from:10.18332/tid/119324Open DOISearch in Google Scholar
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with-COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054–1062ZhouFYuTDuRFanGLiuYLiuZClinical course and risk factors for mortality of adult inpatients with-COVID-19 in Wuhan, China: a retrospective cohort study2020395102291054106210.1016/S0140-6736(20)30566-3Search in Google Scholar
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020; Published Online 12 March 2020. Available from: doi: 10.1016/S1473-3099(20)30195-XBaudDQiXNielsen-SainesKMussoDPomarLFavreGReal estimates of mortality following COVID-19 infection2020Published Online 12 March 2020. Available from:10.1016/S1473-3099(20)30195-XOpen DOISearch in Google Scholar
Liu W, Tao Z-W, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal. [Publish Ahead of Print] 28 February 2020. Available from: doi: 10.1097/CM9.0000000000000775.LiuWTaoZ-WLeiWMing-LiYKuiLLingZAnalysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease[Publish Ahead of Print] 28 February 2020. Available from:10.1097/CM9.0000000000000775714727932118640Open DOISearch in Google Scholar
Zhang J-J, Dong X, Cao Y-Y, Yuan Y-D, Yang Y-B, Yan Y-Q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7): 1730–1741. Available from: doi: 10.1111/all.14238.ZhangJ-JDongXCaoY-YYuanY-DYangY-BYanY-QClinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China202075717301741Available from:10.1111/all.1423832077115Open DOISearch in Google Scholar
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382: 1708–1720. Available from: doi: 10.1056/NEJMoa2002032.GuanWNiZHuYLiangWOuCHeJClinical characteristics of coronavirus disease 2019 in China202038217081720Available from:10.1056/NEJMoa2002032709281932109013Open DOISearch in Google Scholar
Wang J, Luo Q, Chen R, Chen T, Li J. Susceptibility analysis of COVID-19 in smokers based on ACE2. [Preprints] 2020. Available from: doi: 10.20944/preprints202003.0078.v1WangJLuoQChenRChenTLiJ[Preprints]2020Available from:10.20944/preprints202003.0078.v1Open DOISearch in Google Scholar
Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine. 2020;9: 841.BrakeSJBarnsleyKLuWMcAlindenKDEapenMSSohalSSSmoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)2020984110.3390/jcm9030841Search in Google Scholar
Leung JM, Yang CX, Tam A, Shaipanich T, Hackett T-L, Singhera GK, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. European Respiratory Journal. medRxiv 2020.03.18.20038455. Available from: doi: 10.1101/2020.03.18.20038455.LeungJMYangCXTamAShaipanichTHackettT-LSingheraGKACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19medRxiv 2020.03.18.20038455. Available from:10.1101/2020.03.18.20038455Open DOISearch in Google Scholar
Zhou W. The coronavirus prevention handbook: 101 science based tips that could save your life. Wuhan, China: Hubei Science and Technology Press; 2020: p. 68. ISBN:978-5107-6241-1.ZhouWWuhan, ChinaHubei Science and Technology Press202068ISBN:978-5107-6241-1.Search in Google Scholar
Farsalinos K. Smoking, vaping and the coronavirus (COVID-19) epidemic: rumours vs. evidence; 2020. Available from: http://www.ecigarette-research.org/research/index.php/whats-new/2020/278-coronaFarsalinosK2020Available from: http://www.ecigarette-research.org/research/index.php/whats-new/2020/278-corona10.32388/Z69O8ASearch in Google Scholar
Sussman R, Escrig C. Vaping and SARS-CoV-2 and COVID-19 technical information for vapers. 2020. Available from: https://www.sigmagazine.it.SussmanREscrigC2020Available from: https://www.sigmagazine.it.Search in Google Scholar
Glantz St. A. Reduce your risk of serious lung disease caused by corona virus by quitting smoking and vaping. 2020, Glantz St. A. 2020;6 March, Center of Tobacco Control Research an Education. Available from: https://tobacco.ucsf.edu/reduce-your-risk-serious-lung-disease-caused-corona-virus-quittingsmokingand-vaping.Glantz St.A.2020Glantz St. A. 2020;6 March, Center of Tobacco Control Research an Education. Available from: https://tobacco.ucsf.edu/reduce-your-risk-serious-lung-disease-caused-corona-virus-quittingsmokingand-vaping.Search in Google Scholar
Gotts JE, et al. What are the respiratory effects of e-cigarettes? BMJ. 2019;366: l5275. NIDA; 24 March 2020. Available from: doi: 10.1136/bmj.l5275.GottsJEWhat are the respiratory effects of e-cigarettes?2019366l5275NIDA; 24 March 2020. Available from:10.1136/bmj.l5275Open DOISearch in Google Scholar
Volkow N. COVID-19: potential implications for individuals with substance use disorders. Available from: https://www.drugabuse.gov/about-nida/noras-blog/2020/03/covid-19-potential-implications-individuals-substance-use-disorders [Accessed 1st April 2020].VolkowNAvailable from: https://www.drugabuse.gov/about-nida/noras-blog/2020/03/covid-19-potential-implications-individuals-substance-use-disorders [Accessed 1st April 2020].Search in Google Scholar
Edney A, LaVito A. Prognosis vaping could compound health risks tied to virus. FDA Says, 27 March 2020, 10:28 PM GMT+2. Updated on March 28, 2020, 1:19 AM GMT+2). Available from: https//www.bloomberg.com.EdneyALaVitoAFDA Says, 27 March 2020, 10:28 PM GMT+2. Updated on March 28, 2020, 1:19 AM GMT+2). Available from: https//www.bloomberg.com.Search in Google Scholar
Olds JL, Kabbani N. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal. 2020. Available from: doi: 10.1111/febs.15303.OldsJLKabbaniNIs nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?2020Available from:10.1111/febs.15303Open DOISearch in Google Scholar
Hsieh SJ, Zhuo H, Benowitz NL, Thompson BT, Liu KD, Matthay MA, et al. Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Critical Care Medicine. 2014;42(9): 2058–2068.HsiehSJZhuoHBenowitzNLThompsonBTLiuKDMatthayMAPrevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome20144292058206810.1097/CCM.0000000000000418Search in Google Scholar
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; published online Feb 14. Available from: doi: 10.1016/S1470-2045(20)30096-6.LiangWGuanWChenRWangWLiJXuKCancer patients in SARS-CoV-2 infection: a nationwide analysis in China2020published online Feb 14. Available from:10.1016/S1470-2045(20)30096-6Open DOISearch in Google Scholar
Guan W, Liang W-H, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal. 2020;55(5): 200547. Available from: doi: 10.1183/13993003.00547-2020GuanWLiangW-HZhaoYLiangH-RChenZ-SLiY-MComorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis2020555200547Available from:10.1183/13993003.00547-2020709848532217650Open DOISearch in Google Scholar
Sands MF. Smoking and asthma: never the twain should meet. Annals of Allergy, Asthma and Immunology. 2014;113(5): 502–505. PMID: 25240333, Available from: www.ncbi.nlm.nih.gov/pubmed/25240333.SandsMFSmoking and asthma: never the twain should meet20141135502505PMID: 25240333, Available from: www.ncbi.nlm.nih.gov/pubmed/25240333.10.1016/j.anai.2014.08.01125240333Search in Google Scholar
Cai H. Sex difference and smoking predisposition in patients with COVID-19. The Lancet Respiratory Medicine. 2020;8(4): E20. Available from: https://doi.org/10.1016/S2213-2600(20)30117-XCaiHSex difference and smoking predisposition in patients with COVID-19202084E20Available from: https://doi.org/10.1016/S2213-2600(20)30117-X10.1016/S2213-2600(20)30117-XSearch in Google Scholar